These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11439206)

  • 1. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
    Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
    Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
    Poulsen M; Denham J; Spry N; Lamb D; Peters L; Krawitz H; Penniment M; Williamson S; Tripcony L
    Australas Radiol; 1999 Nov; 43(4):487-94. PubMed ID: 10901965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
    MacKenzie R; Balogh J; Choo R; Franssen E
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?
    Denham JW; Peters LJ; Johansen J; Poulsen M; Lamb DS; Hindley A; O'Brien PC; Spry NA; Penniment M; Krawitz H; Williamson S; Bear J; Tripcony L
    Radiother Oncol; 1999 Aug; 52(2):157-64. PubMed ID: 10577701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
    Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):567-76. PubMed ID: 7790241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
    Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
    Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Daly T; Poulsen MG; Denham JW; Peters LJ; Lamb DS; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
    Radiother Oncol; 2003 Aug; 68(2):113-22. PubMed ID: 12972305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone.
    Poulsen MG; Riddle B; Keller J; Porceddu SV; Tripcony L
    Radiother Oncol; 2008 May; 87(2):253-9. PubMed ID: 18410976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial.
    Grau C; Prakash Agarwal J; Jabeen K; Rab Khan A; Abeyakoon S; Hadjieva T; Wahid I; Turkan S; Tatsuzaki H; Dinshaw KA; Overgaard J
    Radiother Oncol; 2003 Apr; 67(1):17-26. PubMed ID: 12758236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An original accelerated radiotherapy schedule in stage III to IV head and neck cancers. Results in a multicenter setting.
    Allal AS; Monney M; Rosset A; Ozsahin M; Guillemin C
    Strahlenther Onkol; 2000 Jan; 176(1):28-31. PubMed ID: 10650833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity.
    Maciejewski B; Skladowski K; Pilecki B; Taylor JM; Withers RH; Miszczyk L; Zajusz A; Suwinski R
    Radiother Oncol; 1996 Aug; 40(2):137-45. PubMed ID: 8884967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer.
    Jackson SM; Weir LM; Hay JH; Tsang VH; Durham JS
    Radiother Oncol; 1997 Apr; 43(1):39-46. PubMed ID: 9165135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.